SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor
SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor
Recruiting · NCT06350006 · Registry updated 2025-12-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor | CLDN18.2-positive Advanced Solid Tumor | Recruiting | Phase 1 | 2025-12-31 | NCT06350006 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 28 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |